(University College London) Nature Nanotechnology journal reveals how scientists from the London Center for Nanotechnology at UCL are using a nanotechnology to investigate the workings of vancomycin, one of the few antibiotics that can be used to combat increasingly resistant infections such as MRSA. The researchers, led by Rachel McKendry and Gabriel Aeppli, developed ultra-sensitive probes capable of providing new insight into how antibiotics work, paving the way for the development of more effective new drugs.
»»»